Dimensional Fund Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $304M | Sell |
512,739
-15,471
| -3% | -$7.7M | 0.06% | 346 |
|
|
2025
Q4 | $257M | Buy |
528,210
+15,394
| +3% | +$7.17M | 0.05% | 421 |
|
|
2025
Q3 | $215M | Sell |
512,816
-60,918
| -11% | -$20.5M | 0.05% | 496 |
|
|
2025
Q2 | $165M | Sell |
573,734
-50,977
| -8% | -$15.2M | 0.04% | 638 |
|
|
2025
Q1 | $193M | Buy |
624,711
+4,145
| +0.7% | +$1.42M | 0.05% | 497 |
|
|
2024
Q4 | $219M | Sell |
620,566
-466
| -0.1% | -$171K | 0.05% | 436 |
|
|
2024
Q3 | $223M | Buy |
621,032
+35,063
| +6% | +$11.8M | 0.05% | 428 |
|
|
2024
Q2 | $187M | Buy |
585,969
+22,683
| +4% | +$6M | 0.05% | 484 |
|
|
2024
Q1 | $129M | Buy |
563,286
+1,336
| +0.2% | +$301K | 0.04% | 754 |
|
|
2023
Q4 | $124M | Buy |
561,950
+9,962
| +2% | +$2.3M | 0.04% | 727 |
|
|
2023
Q3 | $125M | Buy |
551,988
+17,234
| +3% | +$3.97M | 0.04% | 634 |
|
|
2023
Q2 | $118M | Buy |
534,754
+17,077
| +3% | +$3.78M | 0.04% | 692 |
|
|
2023
Q1 | $116M | Buy |
517,677
+22,169
| +4% | +$5.47M | 0.04% | 680 |
|
|
2022
Q4 | $138K | Sell |
495,508
-33,014
| -6% | -$8.33M | 0.04% | 540 |
|
|
2022
Q3 | $111M | Buy |
528,522
+4,174
| +0.8% | +$933K | 0.04% | 616 |
|
|
2022
Q2 | $124M | Sell |
524,348
-37,618
| -7% | -$7.65M | 0.04% | 566 |
|
|
2022
Q1 | $101M | Sell |
561,966
-12,270
| -2% | -$2.34M | 0.03% | 844 |
|
|
2021
Q4 | $124M | Sell |
574,236
-26,423
| -4% | -$5.19M | 0.04% | 707 |
|
|
2021
Q3 | $111M | Sell |
600,659
-56,936
| -9% | -$11.2M | 0.04% | 750 |
|
|
2021
Q2 | $118M | Sell |
657,595
-96,388
| -13% | -$18.4M | 0.04% | 706 |
|
|
2021
Q1 | $126M | Sell |
753,983
-132,351
| -15% | -$22.1M | 0.04% | 626 |
|
|
2020
Q4 | $135M | Sell |
886,334
-16,421
| -2% | -$2.15M | 0.05% | 515 |
|
|
2020
Q3 | $91.2M | Buy |
902,755
+110,152
| +14% | +$12.1M | 0.04% | 650 |
|
|
2020
Q2 | $95.9M | Sell |
792,603
-106,404
| -12% | -$12M | 0.04% | 591 |
|
|
2020
Q1 | $85.3M | Buy |
899,007
+14,674
| +2% | +$1.39M | 0.04% | 537 |
|
|
2019
Q4 | $77.9M | Buy |
884,333
+34,137
| +4% | +$3M | 0.03% | 973 |
|
|
2019
Q3 | $67.8M | Buy |
850,196
+580
| +0.1% | +$46.7K | 0.03% | 1064 |
|
|
2019
Q2 | $66.3M | Sell |
849,616
-225,227
| -21% | -$21.1M | 0.03% | 1108 |
|
|
2019
Q1 | $126M | Sell |
1,074,843
-14,139
| -1% | -$1.65M | 0.05% | 478 |
|
|
2018
Q4 | $119M | Buy |
1,088,982
+29,427
| +3% | +$3.41M | 0.05% | 409 |
|
|
2018
Q3 | $135M | Buy |
1,059,555
+68,870
| +7% | +$8.52M | 0.05% | 468 |
|
|
2018
Q2 | $112M | Buy |
990,685
+32,611
| +3% | +$3.58M | 0.04% | 565 |
|
|
2018
Q1 | $108M | Buy |
958,074
+10,129
| +1% | +$1.29M | 0.04% | 569 |
|
|
2017
Q4 | $140M | Buy |
947,945
+149,852
| +19% | +$19M | 0.06% | 401 |
|
|
2017
Q3 | $93.5M | Buy |
798,093
+71,333
| +10% | +$9.11M | 0.04% | 636 |
|
|
2017
Q2 | $94.3M | Buy |
726,760
+266,790
| +58% | +$33.3M | 0.04% | 579 |
|
|
2017
Q1 | $62.3M | Buy |
459,970
+8,759
| +2% | +$1.33M | 0.03% | 923 |
|
|
2016
Q4 | $64.7M | Buy |
451,211
+153,165
| +51% | +$19.6M | 0.03% | 839 |
|
|
2016
Q3 | $35.2M | Buy |
298,046
+86,970
| +41% | +$10.4M | 0.02% | 1423 |
|
|
2016
Q2 | $22.4M | Buy |
211,076
+9,258
| +5% | +$1.03M | 0.01% | 1741 |
|
|
2016
Q1 | $22.5M | Buy |
201,818
+63,525
| +46% | +$8.04M | 0.01% | 1718 |
|
|
2015
Q4 | $21.7M | Buy |
138,293
+4,251
| +3% | +$619K | 0.01% | 1719 |
|
|
2015
Q3 | $17.6M | Sell |
134,042
-54,047
| -29% | -$8.67M | 0.01% | 1876 |
|
|
2015
Q2 | $32.7M | Buy |
188,089
+4,236
| +2% | +$762K | 0.02% | 1339 |
|
|
2015
Q1 | $31.7M | Buy |
183,853
+1,341
| +0.7% | +$204K | 0.02% | 1324 |
|
|
2014
Q4 | $23.6M | Sell |
182,512
-1,565
| -0.9% | -$202K | 0.02% | 1571 |
|
|
2014
Q3 | $23.7M | Buy |
184,077
+13,549
| +8% | +$1.4M | 0.02% | 1442 |
|
|
2014
Q2 | $15.1M | Sell |
170,528
-581
| -0.3% | -$55.9K | 0.01% | 1911 |
|
|
2014
Q1 | $16.1M | Buy |
171,109
+2,421
| +1% | +$248K | 0.01% | 1788 |
|
|
2013
Q4 | $19.1M | Buy |
168,688
+4,284
| +3% | +$386K | 0.01% | 1606 |
|
|
2013
Q3 | $13M | Buy |
164,404
+8,299
| +5% | +$607K | 0.01% | 1870 |
|
|
2013
Q2 | $10.3M | Buy |
+156,105
| New | +$10.1M | 0.01% | 1970 |
|
Other funds holding UTHR
ACA
VPM
VCM
Dimensional Fund Advisors's UTHR Position: Q1 2026 in Review
Dimensional Fund Advisors reduced its United Therapeutics (UTHR) stake by 2.9% in Q1 2026, selling an estimated $7.7M and leaving 512,739 shares worth $304M. The position accounts for 0.06% of the portfolio, ranked #346.
Dimensional Fund Advisors first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Dimensional Fund Advisors held 512,739 shares of United Therapeutics worth $304M as of Q1 2026.
- Dimensional Fund Advisors sold 15,471 United Therapeutics shares in Q1 2026, an estimated $7.7M.
- United Therapeutics made up 0.06% of Dimensional Fund Advisors's portfolio in Q1 2026, its #346 holding.
- Dimensional Fund Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.